Podcasts about Obesity

Send us a textWhat if everything you thought you knew about weight loss was wrong? In this powerful conversation, Joey Pinz sits down with Dr. David Plourdé—scientist, author of Solving the Weight Loss Puzzle, and founder of The Plourde Method—to uncover the real science behind lasting fat loss.Dr. Plourdé shares insights from 34 years in the lab, where he studied fat cells, food addiction, and the hidden forces sabotaging our health. From uncovering insidious carbs in everyday foods to exposing the dark side of weight-loss drugs like Ozempic, his revelations will make you rethink nutrition, exercise, and the role of psychology in transformation.✨ Top 3 Highlights:

Dr. Hoffman continues his conversation with UK-based science journalist and author Caroline Williams, author of “Inner Sense: How the New Science of Interoception Can Transform Your Health.”

In this episode of the Intelligent Medicine podcast, Dr. Ronald Hoffman explores the concept of interoception with UK-based science journalist and author Caroline Williams. They discuss her latest book, “Inner Sense: How the New Science of Interoception Can Transform Your Health.” The conversation details the intricate relationship between the mind and body, the importance of bodily self-awareness, and how it impacts mental and physical health. Williams shares insights from her extensive research and practical strategies for enhancing interoception, such as controlled breathing exercises and body scans. They also touch on future advancements and therapeutic applications in the realm of interoception, offering listeners a comprehensive understanding of this emerging science and its potential to revolutionize healthcare.

This episode covers:In this episode, we discuss the truth about GLP-1 weight hormones, why these medications may be overprescribed, how to naturally optimize your own hormone function, and so much more.Ashley Koff, RD, is the founder of the The Better Nutrition Program (BNP), the nutrition course director for UC Irvine's Susan Samueli Integrative Health Institute's Integrative and Functional Medicine Fellowship, and a faculty member at the Integrative and Functional Nutrition Academy (IFNA), where she teaches “An Integrative and Functional Nutrition Approach to Obesity and Weight Management.” She is also the author of the upcoming book Your Best Shot (HarperOne, Jan. 6, 2026). A practitioner for more than 25 years, Koff is leading a transformative movement in personalized nutrition, turning “better, not perfect” choices into practical, sustainable strategies that deliver real health outcomes. Through patient stories and personal experience, she shows that optimal health is not just possible — it's essential to living your fullest life. Koff has been recognized as one of CNN's Top 100 Health Makers, featured in InStyle as “Hollywood's Leading Dietitian,” and selected as Westin's global nutrition ambassador.Links mentioned during this episode:*ENROLL in Reignite Your Metabolism!! https://l.bttr.to/j5wLoAshley's GLP-1 Assessment: https://thebetternutritionprogram.com/glp1-weight-health-hormone-assessment/?utm_source=wellnessyourway&utm_medium=podcast&utm_campaign=ybsAshley's Instagram: https://www.instagram.com/ashleykoffapproved/Ashley's Book (preorder): https://amzn.to/4n8hsjTLyons' Share Instagram: www.instagram.com/thelyonsshareJoin Megan's Newsletter: www.thelyonsshare.org/newsletter

In this episode, Antonia and Andrew discuss the September 17, 2025 issue of JBJS, along with an added dose of entertainment and pop culture. Listen at the gym, on your commute, or whenever your case is on hold!   Link: JBJS website: https://jbjs.org/issue.php   Sponsor: This episode is brought to you by JBJS Clinical Classroom.   Subspecialties: Knee, Hip, Orthopaedic Essentials, Trauma, Spine, Pediatrics, Basic Science, Foot & Ankle, Rehabilitation, Education & Training, Chapters (00:00:03) - Case is On Hold(00:01:15) - JBJS CME: The 90th Anniversary(00:03:53) - Race and spinal fusion outcomes in a managed healthcare(00:08:43) - Healthcare disparities, access and healthcare segregation(00:14:40) - Clinical Equipoise in Knee Replacement Trials(00:20:48) - The issue of clinician equipoise in Osteo Surgery(00:25:52) - Obesity and postoperative knee arthroplasty outcomes(00:32:59) - The obesity issue in knee surgery(00:38:59) - Slipped capital femoral epiphysis by Navias et al(00:40:39) - Coronal and Sagittal Balance following posterior spinal fusion for adolescent id

Dr. Kelly Arps, Dr. Naima Maqsood, and Dr. Sahi Allam discuss modifiable risk factors and lifestyle management of atrial fibrillation with Dr. Prash Sanders. Atrial fibrillation is becoming more prevalent across the world as people are living longer with cardiovascular disease. While much of our current focus lies on the pharmacological and procedural management of atrial fibrillation, several studies have shown that targeted reduction of risk factors, such as obesity, sleep apnea, hypertension, and alcohol use, can also significantly reduce atrial fibrillation burden and symptoms. Today, we discuss the data behind lifestyle management and why it is considered the “4th pillar” of atrial fibrillation treatment. We also explore ways to incorporate prevention strategies into our general cardiology and electrophysiology clinics to better serve the growing atrial fibrillation population. Audio editing for this episode was performed by CardioNerds Intern, Julia Marques Fernandes.  CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls More people have atrial fibrillation because it is being detected earlier using wearable technology, and patients are living longer with subclinical or clinical cardiovascular disease  There are 3 components of atrial fibrillation: an electrical “trigger” + a susceptible substrate (due to age, sex, genetics) + “perpetuators” that cause the trigger to continue stimulating the substrate (lifestyle risk factors such as obesity, smoking, diabetes, etc.)  Obesity is the highest attributable risk factor for atrial fibrillation. Treating obesity often helps to treat other risk factors, such as hypertension and sleep apnea.  Counseling is patient-dependent. Most patients are unable to make major behavioral changes cold-turkey and will need to make small, incremental changes.  Dr. Sanders' tip: He tells his own patients that “atrial fibrillation is the body's response to stress.” The key to treating atrial fibrillation is to control your underlying stressors - procedures and medications are simply band-aids that do not fix the root of the problem.  Notes Notes drafted by Dr. Allam. 1. How common is atrial fibrillation?  Atrial fibrillation is the most common sustained arrhythmia. Currently, an estimated 50-60 million individuals worldwide are estimated to have atrial fibrillation, or roughly 1 in 4 individuals over the age of 45.1  The rising global prevalence of atrial fibrillation can be attributed to the aging of the population, increased rates of obesity, and greater accumulation of cardiovascular risk factors and survival with clinical cardiovascular disease.2 Atrial fibrillation is also being detected earlier through digital and wearable devices.2  Annually, we spend approximately $5,312 per adult on the management of atrial fibrillation in the United States.3  2. What is the underlying pathophysiology of atrial fibrillation? How do risk factors like sleep apnea or obesity “trigger” atrial fibrillation?  For atrial fibrillation to occur, there is an electrical “trigger”, a susceptible substrate (due to age, sex, genetics), and “perpetuators” that allow the trigger to continue stimulating the substrate.2  90% of electrical “triggers” come from the pulmonary veins  “Perpetuators” influence how the autonomic nervous system interacts with the triggers and substrate to perpetuate atrial fibrillation. Sleep apnea, obesity, and other risk factors are the “perpetuators”  Over time, as atrial fibrillation recurs, the substrate remodels to result in persistent atrial fibrillation.  3. What are some of the risk factors for atrial fibrillation and what are the possible benefits of controlling them? 

In this episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Ashley Lucas, a former professional ballerina turned PhD nutritionist and founder of PhD Weight Loss. Dr. Lucas shares her remarkable journey from struggling with under-eating and injury in the ballet world to helping over 11,000 people lose nearly 500,000 pounds by addressing the real root of weight issues: metabolic health.Together, Dr. Jenn and Dr. Ashley expose the myths of “eat less, move more,” unpack the dangers of visceral fat, and explain why true, lasting weight loss is more about hormones and mindset than willpower. They also dive into hot topics like GLP-1 weight loss drugs, protein and macro balance, over-exercise, sleep, and the misunderstood role of fat in our diets.Whether you've battled weight loss plateaus, wondered why BMI is misleading, or want to protect your long-term metabolic health, this conversation offers a science-backed roadmap for sustainable change.In This Episode, You Will Learn:How Dr. Ashley's ballet career and health collapse led her to study metabolismWhy “eat less, move more” fails most peopleThe unique dangers of visceral (belly) fat and how it drives diseaseWhy GLP-1 drugs may create more problems than they solveHow protein, fat, and carb balance impacts weight loss and metabolic healthWhy BMI is outdated—and better tools for measuring healthThe role of sleep, stress, and mindset in weight managementWhy over-exercising can sabotage fat lossPractical steps to reset metabolism and protect muscle mass

Have you heard about people buying weight loss medications from unregulated sources online? The rise of black market weight loss drugs is putting lives at risk. In this episode, I discuss the concerning trend of people purchasing Retatrutide—a medication still in clinical trials—through illegal channels. Known as the "Godzilla Jab" for its potential power, early studies suggest this drug could help people lose up to 24% of their body weight. I explain what Retatrutide is and how it compares to FDA-approved medications like Ozempic, Wegovy, Zepbound, and Mounjaro. We explore why people take dangerous risks with black market drugs, from social media hype to cost concerns and access issues. Most importantly, I share the serious health and legal risks of buying unregulated medications and provide clear guidelines for safely accessing weight loss treatments through licensed providers. Tune in to learn how to protect yourself and make informed decisions about weight loss medications the safe way.   Episode Highlights: What is Retatrutide The dangers of purchasing unregulated medications online Factors driving people to illegal sources Legal risks of buying unapproved drugs and potential health complications from unregulated substances Safe Medication Practices Understanding that medication works best when combined with healthy eating, physical activity, adequate rest, and emotional support   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Send us a textThe effects of protein restriction on metabolism, liver hormones, brain, and behavior.Episode Summary: Dr. Christopher Morrison talks about how animals sense and prioritize nutrients like protein, discussing defense mechanisms for essentials such as oxygen, water, sodium, and energy; the brain's role in detecting protein deprivation via signals like FGF21; trade-offs between growth, reproduction, and longevity under protein restriction; and reconciling high-protein diets for satiety and muscle maintenance with low-protein benefits for metabolic health and lifespan extension.About the guest: Christopher Morrison, PhD is a professor and researcher at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, where he has worked for over 22 years focusing on nutrition, metabolism, and chronic diseases like obesity and diabetes.Discussion Points:The body prioritizes nutrients hierarchically: oxygen and water first, then sodium, energy, and protein, with weaker defenses for carbs or fats.Animals develop specific appetites for deprived nutrients, like salt or protein, often through post-ingestive learning rather than just taste.Protein restriction (e.g., 5% vs. 20% in diets) increases food intake and energy expenditure in mice to maintain protein levels, even at the cost of extra calories.FGF21, a liver hormone, signals protein deprivation to the brain (via NTS region), driving protein-seeking behavior and metabolic changes; it's essential for low-protein responses.Protein restriction extends lifespan in lab animals by suppressing growth signals like IGF-1 and mTOR, but may impair immunity or wound healing in real-world conditions.High protein aids satiety, weight loss, and muscle building, but overconsumption may shorten lifespan; optimal intake depends on age, activity, and goals (e.g., not for pregnant or elderly).No one-size-fits-all for protein: mild restriction may benefit middle-aged sedentary people for health, while athletes need more; balance avoids excesses.Related content:M&M 106: Diet, Macronutrients, Micronutrients, Taste, Whole vs. Processed Food, Obesity & Weight Loss, Comparative Biology of Feeding Behavior | Stephen Simpson & David Raubenheimer*Not medical advice.Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Sean L. Huddleston will step down as president of Martin University at the end of November. 2024 saw the second highest number of hate crimes reported in the U.S. since the FBI started collecting data. A new group aimed at encouraging independent candidates in Indiana will launch a statewide ad campaign. The Indiana Youth Institute is highlighting the rise of obesity in central Indiana youth. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

What if a drug could help chemotherapy patients continue treatment without painful side effects? Hoth Therapeutics (NASDAQ: HOTH) is making that possible by developing innovative treatments that address unmet medical needs and help patients maintain their therapy safely.In this interview, CEO Robb Knie discusses HT001, the company's lead drug currently in Phase 2 trials for chemotherapy-induced rash, and HTKIT, which shows promise in cancer treatment. He also shares how the company is advancing programs for Alzheimer's and obesity, including an obesity drug licensed from the U.S. Department of Veterans Affairs.With a diversified pipeline, a patient-focused approach, and strategic use of AI to de-risk and accelerate development, Hoth Therapeutics is positioning itself as a biotech company to watch.Learn more about Hoth Therapeutics: https://hoththerapeutics.comWatch the full YouTube interview here: https://youtu.be/AYQa3g6dVLA?si=w_zDH0TaSxP3m6JiAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Join experts in obesity, Robert Kushner, MD, Michael Knight, MD, and Amanda Velazquez, MD, as they discuss impactful communication for patients with obesity. Bob Kushner, MD  Amanda Velazquez, MB, DABOM Michael Knight, MD, MSHP, FACP, DABOM

Elan and Kiki are the Co-founders at Sourmilk, a modern Greek-style yogurt made for your gut. WHAT WE GO OVER:Co-Founders' origin story at StanfordCease & Desist, Benny -> Sourmilk The bet on yogurt, reverse engineering the product to truly support gut healthThe Sourmilk "Drug Deal Model" - 5k units in 7 weeks! Who the founders look up toThe dairy company they think gets acquired nextCONNECT WITH US:Connect with Vasa on LinkedinConnect with Elan and Kiki on LinkedInPerfy's websiteCPGSPN by Growthbuster, a CPG newsletter with a sports themeCheck out Sourmilk SPONSOR:Food Chained is a Perfy podcast brought to you by Growthbuster. Growthbuster is a team of creatives and strategists that help food & beverage brands grow. Check out Growthbuster's newsletter, CPGSPN here. 

Episode Highlights With CourtneyWhy this conversation is so important right now, and why 74% of adults are obese or overweight and over 50% of kids areNon-alcoholic fatty liver disease didn't even exist decades ago, and it's now rampantHer own journey into health and wellness The biggest offenders and contributors to why we're seeing this drastic rise60% of Americans' diets are coming from ultra-processed foodsThe real problem with food dyes and the sneaky places they're hidingLinks between food dyes and behavioral issues, cancer, and why most countries have banned themWhy glyphosate is such a big problemMisleading food labeling and the illusion of choice The real deal on vegetable oils and how these are impacting our food supply Look at what has changed so much in the last 50 years in our food supply- our genes don't change that fast20% of Americans' calories come from seed oilsThe role of big agriculture and government subsidiesUnderstanding GMOs and how they impact usWe're only as healthy as our soil is Count chemicals, not calories- why we are overfed and under nourished Two great films on this: Common Ground and Kiss the Ground Resources We MentionHer InstagramRealfoodology - WebsiteRealfoodology - PodcastCommon Ground DocumentaryKiss the Ground DocumentaryMy Health Forward - Regenerative Farms

Send us a textShannon Davis, RD is a returning guest on our show! Be sure to check out her first appearance on episode 857 of Boundless Body Radio! Shannon Davis, RD is a Registered Dietitian with 19 years of expertise in metabolic health, specializing in the prevention and reversal of chronic diseases through evidence-based, root-cause approaches. Her diverse clinical background includes organ transplants, bariatrics, sports nutrition, nephrology, and pharmaceutical sales.As the founder of her own virtual preventative and metabolic health practice, Shannon empowers clients to overcome insulin resistance and achieve lasting health by moving beyond traditional calorie-counting models. She integrates strategies such as low-carb, ketogenic, and carnivore diets, intermittent fasting, nutraceutical support, and exercise to promote optimal metabolic function.Shannon serves on the founding board of the American Diabetes Society and is a coach for Dr. Ben Bikman's Insulin IQ program. Additionally, she is a practicing dietitian at OWNA Health, working alongside renowned endocrinologist Dr. Mariela Glandt.A passionate advocate for metabolic health, Shannon is dedicated to educating others on the critical role of insulin resistance in chronic disease. Shannon also enjoys CrossFit, weightlifting, running, horseback riding, golf, and exploring the outdoors.Find Shannon at-FB- Functional Foodie RxIG- @sldavis6580LK- Sharon Davis, RDUnicity Take Control Americas 2025 Eventhttps://linktr.ee/shannondavisFind Boundless Body at- myboundlessbody.com Book a session with us here!

Episode 25:37 Here's 4 Ways To Lower Your A1C Level Naturally  More than 100 million Americans have elevated blood sugar levels… and don't even know it! Another 50 million have elevated levels and DO know it. That's not good! It's not good because elevated blood sugar levels lead to deadly sicknesses and diseases. Disease such as Obesity, Type 2 Diabetes, Heart Disease, Cancer, Alzheimer's and Dementia. So, how do you know if blood sugar levels are elevated? It's easy! Simply have your doctor order a blood test known as an “A1C Test.” If your A1C score is above 5.4 it's considered to be elevated (high).  It also places you at high risk for developing any of the diseases mentioned above. Fortunately, elevated levels of blood sugar… high A1C levels… can be reduced naturally, without drugs. On this episode I discuss four specific tactics for doing just that. Four lifestyle habits that you can begin to implement immediately that will help reduce your blood sugar levels and decrease your risk of developing a chronic disease.  Be sure to give this episode a good listen and, as always, share it with a friend. Thanks! ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the “Symptom Survey” and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

               * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Dr. Hoffman continues his conversation with Dr. Martin Picard, Chair in Energy and Health, and Professor of Behavioral Medicine at Columbia University, as well as head of the Mitochondrial PsychoBiology Lab.

Dr. Martin Picard, Chair in Energy and Health, and Professor of Behavioral Medicine at Columbia University, as well as head of the Mitochondrial PsychoBiology Lab, delves into the complex functions of mitochondria beyond their well-known role as cellular powerhouses. Dr. Picard shares his journey from biology to psychobiology, exploring the intersection between mitochondrial function, mental health, and overall well-being. He discusses how mitochondria not only produce energy but also influence behaviors, stress responses, and healing processes. The conversation highlights recent findings on mitochondrial roles in psychiatric disorders, the impact of diet and lifestyle on mitochondrial health, and the potential of ketogenic diets in treating psychiatric conditions. Dr. Picard also previews his upcoming book on understanding life and health from an energetic perspective. The episode emphasizes a holistic approach to health, integrating mind-body practices and lifestyle changes to support mitochondrial function.

Meal replacements are an excellent tool for weight management. But they aren't the same as protein shakes. Medical weight-loss dietitian Julia Axelbaum joins me to clear up the confusion, define the difference (they are not interchangeable), and map out exactly when to use each—on their own or alongside evidence-based tools like GLP-1s. You'll walk away with a 3-step label checklist you can teach patients, practical strategies to curb evening cravings, and a step-by-step plan for transitioning patients back to real food without the weight regain.  Join the Obesity Medicine Nutrition Course! Use POD15 for 15% off!Get 40% off Cozy Earth Sheets here. Use code EXAM at checkout.Resources:Episode 93: Contaminated Protein SupplementsFREEBIE: How to Choose a Protein SupplementConnect with Julia at https://www.formhealth.co/Got a nutrition question? Send me a voicemail. Any Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

My friend Bill Streetman, who I have known for many years, wrote a book about his bariatric journey. The book is called Simple... not Easy!: Escaping the Prison of Obesity. Bill has been super active in the bariatric community, inspiring hundreds of people who have also been dealing with obesity. During our conversation, Bill and I talk about how weight loss is about so much more than pounds lost, but is a path to living life fully! The Weight Loss Winformation Podcast gives you essential psychological information to help you lose weight and more importantly, to help keep you at a healthy weight for your body! No matter how you are working to lose weight and no matter how much weight you want to lose, Weight Loss Winformation will keep you moving in a positive direction.Resources:BariAfterare: www.bariaftercare.comConnie Stapleton PhD website: www.conniestapletonphd.comBariAftercare website: https://www.conniestapletonphd.com/bariaftercareBariAftercare Facebook page (for members only): https://www.facebook.com/groups/BariAftercareKevin Stephens: Your Bariatric Buddy   https://www.facebook.com/groups/yourbariatricbuddy/peopleInstagram: @cale101 (Caleshia Haynes)Instagram: @therealbariboss (Tabitha Johnson)Instagram @drsusanmitchell (Dr. Susan Mitchell)Instagram: @lauraleepreston (Laura Preston)ProCare Vitamins (10% off with code ConnieStapleton)Rob DiMedio: https://www.busybariatrics.com/Dr. Joan Brugman: drjbrugman@outlook.comDr. Susan Mitchell:https://www.facebook.com/DrSusanMitchellhttps://www.facebook.com/bariatricsurgerystrategiesBill Streetman: https://www.facebook.com/bill.streetmanSimple... not Easy!: Escaping the Prison of Obesity

EPISODE 145 | Trumpspiracies: What a Tangled Web Ever since Donald Trump first decided to run for the highest office in the United States, he has promoted an astonishing number of conspiracy theories. It's almost as if a New York real estate baron famous for lying to clients, not paying his bills and exploiting loopholes for his own benefit had learned, somewhere along the way, that “truth” is a slippery subject. And because he's not a very deep thinker, he has, like many people, confused truth with facts. Like what we do? Then buy us a beer or three via our page on Buy Me a Coffee.  Review us here or on IMDb. And seriously, subscribe, will ya?  SECTIONS 02:25 - Liar, Liar - 9/11 nonsense, open season on Muslims 08:50 - Would I Lie to You? - Boogeyman Obama, Birtherism  19:02 - Suspicious Minds - The Clintons, Biden, robot clones, Canada, assassinations, self delusion as super power 29:22 - Liar, Liar, Burn in Hell - Science, medicine, the Great Replacement, crime stats, Britain First, tweets and retweets 38:31 - Dance Little Liar - Haitians eating pets, conspiracy theorists in his administration 46;40 - Liar (It Takes One to Know One) - 2016 Russian election interference, Spygate, #Obamagate, Trump's impeachments Music by Fanette Ronjat More Info 58 Donald Trump Conspiracy Theories (And Counting!): The Definitive Trump Conspiracy Guide (from 2016) President Obama's Long History of Insulting Donald Trump The birth of the Obama 'birther' conspiracy ‘Birtherism,' Trump and anti-Black racism: Conspiracy theorists twist evidence to maintain status quo Trump's history of launching "birther" conspiracy theories against rivals Trump promotes 'totally baseless' birther conspiracy theory against Nikki Haley Trump claims media 'dishonest' over crowd photos Comparison: Donald Trump and Barack Obama's inauguration crowds Trump's crowd-size obsession to be tested at inauguration after 2017 controversy The surprising reason why the Park Service won't count folks at Trump's inauguration 'It eats him alive inside': Trump's latest attack shows endless obsession with Obama 12 false claims Trump has made about Obama since last month (from 2020) Trump's obsession with Obama took an ominous turn this week Twitter use by Donald Trump A farewell to @realDonaldTrump, gone after 57,000 tweets FBI 2019 crime statistics Trump Says He's Going To Check If ‘Somebody Stole' Fort Knox $400 Billion Gold Supply. What We Know. No Evidence Haitian Immigrants Are Eating Ducks, Geese or Pets in Springfield, Ohio ‘They're eating the pets:' Trump, Vance earn PolitiFact's Lie of the Year for claims about Haitians Altogether fitting and proper? Trump repeatedly compares himself to Abraham Lincoln Donald Trump: Height, Weight, Obesity, and Documentation Seriously, What Is “Obamagate”? | The Daily Social Distancing Show (video) How Trump's Obsession With a Conspiracy Theory Led to the Impeachment Crisis Trump impeachment trial: Conspiracy theories and fidget spinners How the Senate Could Bar Donald Trump from Running for President in 2024 Follow us on social: Facebook X (Twitter) Other Podcasts by Derek DeWitt DIGITAL SIGNAGE DONE RIGHT - Winner of a Gold Quill Award, Gold MarCom Award, AVA Digital Award Gold, Silver Davey Award, and Communicator Award of Excellence, and on numerous top 10 podcast lists.  PRAGUE TIMES - A city is more than just a location - it's a kaleidoscope of history, places, people and trends. This podcast looks at Prague, in the center of Europe, from a number of perspectives, including what it is now, what is has been and where it's going. It's Prague THEN, Prague NOW, Prague LATER 

Researchers at the Liggins Institute at Auckland University believe a capsule of healthy gut bugs could change the future of obesity treatment. 

There are now more obese school-aged children worldwide than those who are underweight. That's according to a new report from UNICEF, which found 1 in 10 kids around the globe now suffer from obesity. To discuss further we heard from Dietician Orla Walsh.

In this interview, Dr.SHIVA Ayyadurai, MIT PhD, Inventor of Email, Scientist, Engineer and Candidate for President, Talks about Ginkgo biloba on Alzheimer's Disease: A Whole Systems Approach

Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School of Medicine, joins Lisa Dent to discuss several pharmaceutical stories. And, as always, he answers questions from listeners.

Do you know the latest in obesity management? Credit available for this activity expires: 9/5/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002891?ecd=bdc_podcast_libsyn_mscpedu

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Ever wonder why the same weight loss plan can work wonders for one person but barely move the needle for another?Or why some people respond really well to medications like Wegovy, while others struggle with side effects or see minimal results? That's exactly what precision obesity medicine aims to answer—and today, we're diving into it with one of the world's leading experts.We're joined by Dr. Andres Acosta, a true pioneer in obesity medicine and the creator of the obesity phenotypes concept. He's board-certified in internal medicine, gastroenterology, hepatology, obesity medicine, and nutrition. At the Mayo Clinic, he co-directs the Nutrition and Obesity Research Program and leads the Precision Medicine for Obesity program, focusing on matching the right treatment to the right patient with fewer side effects.Dr. Acosta's research is supported by the National Institutes of Health, with more than 145 peer-reviewed papers in top journals. His work has been featured in The New York Times, TIME, CNN, and NPR, and he's earned “40 Under 40” recognition and co-founded Genomic Sciences—just a glimpse of his many accomplishments.If you've ever felt frustrated by trial-and-error weight loss or wondered if there's a more scientific way to find what actually works for you, you're going to want to hear what Dr. Acosta shares in this episode.Connect with Dr. Acosta:Mayo Clinic: mayu.eduPhenomix Sciences: WebsiteConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

In this final episode with Kristen from @EveryDayisDarling, Dr. Plaster and Nurse Practitioner Amber Foster dive into the reality of facing online criticism during a weight loss journey. Kristen opens up about how she's learned to navigate “trolls” and “haters,” why there's no shame in using GLP-1 medications, and how her story has inspired others to take charge of their health.This conversation is a reminder that:Obesity is a disease, not a failure.Medications are tools — not shortcuts.Your journey is yours, no one else's.Whether you're considering treatment options or just need encouragement to tune out the noise, this episode will leave you empowered to focus on what matters most: your health and well-being. Hosted on Acast. See acast.com/privacy for more information.

How obesity is reframed as a chronic disease, and what this means for clinical care Practical ways to move beyond BMI in assessment and monitoring When to think about pharmacotherapy and when surgery may be appropriate The healthcare professional's role in supporting long-term outcomes and continuity of care Host: Dr David Lim | Total Time: 35 mins Expert: Dr Melissa Beitner, Bariatric Surgeon and Obesity Medicine Specialist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

Mikki takes a deep dive into BMI, obesity, and a major shift in how obesity is being redefined in the scientific and medical community. Drawing on a recent Lancet Diabetes & Endocrinology Commission report and new cohort data from the All of Us research program, she unpacks why BMI alone is an inadequate measure, how new definitions of preclinical and clinical obesity provide more nuance, and what this means for individuals, clinicians, and policymakers. This conversation highlights the importance of looking beyond the scale to understand true metabolic risk and the wider societal costs of obesity. Listeners will come away with a clearer understanding of why obesity is being reframed as a chronic systemic condition—and why it matters for health outcomes and resource allocation.Highlights:Why BMI falls short in measuring individual health risk.The Lancet Commission's new framework redefining obesity as a chronic condition.Difference between preclinical vs clinical obesity.Study findings: 1 in 5 people with “normal BMI” may still be classified as obese under the new definition.Implications for clinicians, policy, and public health. Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwillidenSave 20% on all Nuzest Products WORLDWIDE with the code MIKKI at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz supplement: MIKKI saves you 25% at www.curranz.co.nz or www.curranz.co.uk off your first order

Neste episódio, vamos analisar criticamente o estudo brasileiro publicado no prestigiado periódico Neurology, que virou manchete no mundo todo ao afirmar que sete adoçantes artificiais estariam associados a declínio cognitivo acelerado.À primeira vista, parece alarmante. Mas, quando olhamos com lupa, o estudo se revela um festival de problemas metodológicos e incongruências:É observacional, baseado em questionário de frequência alimentar (FFQ), incapaz de medir miligramas de adoçantes.Foram feitas dezenas de comparações sem ajuste, terreno fértil para falsos positivos.As diferenças absolutas nas curvas são microscópicas, irrelevantes do ponto de vista clínico.Os resultados são cheios de contradições: a mesma substância aparece como “protetora” em um grupo e “prejudicial” em outro.O caso mais bizarro é o da tagatose, um adoçante que sequer é consumido no Brasil, mas que apareceu associado a declínio cognitivo porque os autores usaram uma tabela gringa de composição de alimentos.Até os polióis em miligramas, que não representam consumo real, foram parar nos gráficos como supostos vilões.No fim, o que o estudo mostra não é toxicidade universal dos adoçantes, mas sim que os usuários desses produtos já eram pessoas com mais diabetes, mais hipertensão e maior risco de declínio cognitivo desde o início. É o clássico viés por indicação.Neste episódio, vamos destrinchar cada detalhe, explicar como essas associações espúrias se formam e discutir o perigo de manchetes sensacionalistas que transformam estatística em pânico.Links relacionados:Comida Sem Filtro #27 – “Por Que O Ovo Que Te Faz Bem Hoje Te Mata Amanhã?”Comida Sem Filtro #36 – Assim Fica Difícil, BBCComida Sem Filtro #42 – A Carne QuânticaComida Sem Filtro #46 – Não Caia Em Epidemiologia Nutricional!Comida Sem Filtro #59 – Diretrizes Podem Mudar?Comida Sem Filtro #70 – Adoçantes Artificiais Aumentam Risco Cardiovascular?Comida Sem Filtro #99 – “O Mistério Do Sorvete”Comida Sem Filtro #151 – A Tortura Dos Dados – Parte 1: Os Dados Confessam O Que Você QuiserComida Sem Filtro #152 – A Tortura Dos Dados – Parte 2: Carne Vermelha No MultiversoComida Sem Filtro #153 – A Tortura Dos Dados – Parte3: O Viés De PublicaçãoComida Sem Filtro #175 – Low-Carb Causa Diabetes?Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese SubjectsSemaglutide and Cardiovascular Outcomes in Obesity without DiabetesEffects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infection: randomised controlled trialEstamos no Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Souto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sari Fontana⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Para ser avisado sobre cada novo episódio e receber os links das matérias mencionadas e as referências bibliográficas por e-mail, cadastre-se gratuitamente em ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drsouto.com.br/podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠"Dance of the Sugar Plum Fairy"Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://creativecommons.org/licenses/by/3.0/⁠⁠⁠⁠⁠⁠⁠

This week on Dawnversations, I'm joined by Gretchen Zimmermann, MBA, RD, LD, CDCES, CSOWM, VP of Clinical Strategy at Vida Health. Gretchen has spent her career cutting through the noise around obesity and nutrition — and in this episode, she helps us separate fact from fiction.We bust some of the most common myths about weight loss, obesity, and “quick fix” diets, plus talk about why lasting health is a whole lot more complex than calorie counts and willpower. We even touch on The Biggest Loser and what that show got wrong (and right) about changing your body.Whether you've struggled with weight yourself, or just want a clearer picture of how nutrition and obesity really work, this conversation is packed with insight and honesty. ✨ Listen in and walk away with a fresh perspective on food, health, and what it really takes to feel your best.Find Gretchen Zimmermann here:INSTAGRAM: @gretchenzimmermann.rdVida Health | www.vida.com

Ozempic-style appetite-suppressing drugs are coming for our dogs.Headlines are already calling them “Pawzempic” — implants that promise to “fix” the so-called canine obesity epidemic by turning off your dog's hunger. But here's the thing: our dogs don't feed themselves.In this FETCH First Friday episode, we dive beneath the headlines to explore what this trend really reveals — not just about pet health, but about us as guardians, consumers, and culture-makers.Because when we reach for a jab before we ask deeper questions, we risk missing the truth: obesity isn't the root cause — it's a symptom.What You'll Learn in This Episode* The rise of “Pawzempic” → How GLP-1 drugs work, what's being developed for dogs, and why the marketing is so seductive* The root causes of canine obesity → From ultra-processed pet food to lack of enrichment, environmental stress, and even our own emotional projection* The microbiome connection → Why weight is about more than calories, and how gut health shapes metabolism, inflammation, and wellbeing* The deeper questions → Are we unconsciously transferring human struggles with weight, control, and shame onto our dogs? What happens when we silence natural hunger cues instead of listening to them?* A different path forward → Species-appropriate fresh food, microbiome-friendly choices, emotional co-regulation, and practical, natural ways to support your dog's health — without shame or shortcutsWhy This MattersThis isn't just a conversation about weight loss. It's about the stories we're told — and sold — about our dogs, our bodies, and what “health” really means.It's about reclaiming our role as guardians, not consumers. About moving from control to connection. And about creating a life where our dogs thrive because we're finally willing to ask:✨ What's actually causing imbalance?
✨ Who profits when we medicate the symptoms instead of healing the system?
✨ And how can we step back into relationship — with our dogs, with food, and with ourselves?Your dog isn't broken. But the systems around them often are.Grab your copy of our guide to speaking with your vet, which is included in our free FETCH Starter Pack: https://www.learnfetch.com/pages/fetch-starter-packJoin FETCH First Light, our free Facebook group for like-hearted guardians https://facebook.com/groups/fetchfirstlightWSAVA Body Condition Score Guide: https://wsava.org/wp-content/uploads/2020/01/Body-Condition-Score-Dog.pdfIf you would like to attend the Mind Body Spirit Festival in Birmingham UK November 14-16th, and would like to receive a 25% discount on one-day standard tickets, you can use the following affiliate link and discount code at checkout! Full disclosure, as exhibitors at the festival, Stacey Renphrey and I receive a commission, at no cost to you, when you purchase your tickets using this affiliate link.Affiliate Link to Purchase Tickets: https://www.eventbrite.co.uk/e/mind-body-spirit-festival-nec-birmingham-2025-tickets-1091070704849?aff=learnfetchDiscount Code: NEC-25EXHIFAMDisclaimer: The information provided is for educational purposes only and is not intended to diagnose or treat any disease, or replace medical guidance. Please speak with your veterinarian.

I have high LDL cholesterol and a '0' calcium score.  Why does my doctor insist I take a statin?How much vitamin D should I take?  Which product do you recommend?Some doctors assert omega-3s are proinflammatory.  What say you?Study: Magnesium intake may be beneficial in preventing pancreatic cancerDo you have any products to regrow hair?I have a calcium score, but prefer to avoid Lipitor.

Potato intake and diabetes risk.How much daily leucine is required to regain muscle?

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review:   1.     Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity  - NEJM   2.     Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3)– Lancet Diabetes Endocrinology    3.     Nutritional priorities to support GLP-1 therapy for Obesity – A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - American Journal of Clinical Nutrition 4.     Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events – Diab Care 5.     Tirzepatide as Compared with Semaglutide for the Treatment of Obesity – NEJM For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Henry Riley, reporter with LBC in London and Professor Donal O'Shea, HSE's National Clinical Lead for Obesity

I have been consistent in my beliefs and concepts when it comes to nutrition on this show but that doesn't stop me from hearing other perspectives and learning alternative ways to help my clients reach their goals. Today's episode might seem out of left field but the story and conviction of my guest today is definitely worth a listen. Mark Ennis is an online fitness coach that has been through just about everything health wise which he explains in the beginning of the podcast. We explore his perspective on carbohydrates, protein, mindset, and more.   Time Stamps:   (0:30) Keto/Carnivore Diet (2:05) Mark's Story (18:10) Mark's Opinion on Carbohydrates (23:48) Increasing Protein (31:25) Mindset Work (44:35) Accountability and Support (56:40) Muscle Loss In Later Life ------------------- TikTok: @fitnessbeyondtime01   Instagram: https://www.instagram.com/fitnessbeyondtime01/ ------------------- Instagram: https://www.instagram.com/carolcovinofitness/ -------------------- My YouTube Channel: http://youtube.com/@carolcovinofitness -------------------- My Book:  FINDING PURPOSE IN THE PAUSE

Visit All Our Links https://linktr.ee/manonthemounjaro GLP-1 Heart Study https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the

The FDA has approved a generic version of liraglutide injection, expanding access to obesity treatment by lowering costs and broadening eligibility across adults and adolescents, though safety monitoring remains essential. A JAMA Network Open study found that overweight older adults had lower 30-day mortality after elective surgery compared to those of normal weight, highlighting the “obesity paradox” in surgical risk assessment. Finally, a new rapid, culture-free diagnostic method for sepsis can identify pathogens within two hours using microfluidics and deep learning, offering significant potential to improve survival in critically ill patients.

Join Dr. Tom Rogers on this week's episode of The Common Sense MD as he tackles one of the most pressing and often misunderstood health issues of our time: obesity. Dr. Rogers explores why obesity is now widely recognized as a disease—and not simply a matter of willpower. Drawing from recent medical research and decades of clinical experience, he breaks down the impact of weight bias, the limitations of traditional diets, and the life-changing potential of revolutionary new medications like GLP-1s and GIPs.Discover why these treatments are being hailed as the greatest medical breakthrough of the 21st century, how they're changing lives, and why addressing the root causes of obesity can transform a patient's overall health. Dr. Rogers also shares candid thoughts on the importance of compassion in medical practice, the social stigma around obesity, and the future of fat acceptance and weight loss therapy.Whether you're a healthcare professional, someone struggling with weight, or simply want to understand more about this major health issue, this episode cuts through the noise with clear, actionable advice. Tune in and learn why treating obesity is about so much more than just the numbers on a scale.This episode is for educational purposes only and does not constitute official medical advice. Please consult with a licensed healthcare provider for personalized care.What did you think of this episode of the podcast? Let us know by leaving a review!Connect with Performance Medicine!Check out our new online vitamin store:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/shop/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for our weekly newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/doctors-note-sign-up/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PMedicine⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PerformancemedicineTN⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Performance Medicine

Nate is the Founder at Express Checkout, a newsletter covering all things CPG, one of the most respected voices in CPG, and a friend to all. WHAT WE GO OVER:Newtopia NowSharing booths at tradeshowsNate's favorite brandsSome hot take acquisition predictionsNate's thoughts on Pepsi's new gut health sodasCONNECT WITH US:Connect with Vasa on LinkedInConnect with Nate on LinkedInPerfy's websiteCPGSPN by Growthbuster, a CPG newsletter with a sports themeSubscribe to Express CheckoutSPONSOR:Food Chained is a Perfy podcast brought to you by Growthbuster. Growthbuster is a team of creatives and strategists that help food & beverage brands and local businesses grow. Check out Growthbuster's newsletter, CPGSPN here. 

Takeaways Menopausal women often prioritize weight gain concerns over other symptoms.The study observed an association between hormone therapy and weight loss with GLP-1 medications.Retrospective studies have limitations but can provide valuable insights.Future research should focus on randomized controlled trials to confirm findings.The relationship between estrogen and GLP-1 signaling needs further exploration.Funding for research can be challenging, especially for early career investigators.Collaboration between different specialties is crucial for comprehensive patient care.The media often misrepresents research findings, leading to misconceptions.Individualized treatment plans are essential for menopausal women.There is a need for more awareness about the effects of menopause on health.Research Links:Weight loss response to semaglutide in postmenopausal women with and without hormone therapy useCombination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

RFK Jr. issues sharpest ultimatum yet to medical schools: “Start teaching nutrition now or face penalties!” Fast-food outlets continue to abound in teaching hospitals; Once serious causes of flank pain are ruled out, patients are often left to fend for themselves; Potatoes don't increase risk of diabetes—unless you eat French fries; Deep-frying in seed oils can yield harmful byproducts—but so, too, when you substitute with lard; As doctors get more aggressive treating blood pressure, how to minimize medication side effects; New study shows beetroot juice can lower BP by 7 points.

For weight loss, complete avoidance of ultra-processed foods outperforms mere “healthy diet” comprising minimally-processed items; Research fraud undermines anti-dementia drug pipeline; Comprehensive lifestyle modification program scores against cognitive decline; Women's brains especially vulnerable to Omega-3 deficiencies; Bible says “Lame shall walk again” and 21st century science may soon bring about this miracle; Breakthroughs in rheumatoid arthritis treatment.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.We explore the four key habits of people who have successfully maintained significant weight loss, based on findings from the National Weight Control Registry's long-term observational study.• 62% of successful weight maintainers watch less than 10 hours of TV weekly (under 90 minutes daily)• 75% weigh themselves at least once weekly as a data point, not as a measure of self-worth• 78% eat breakfast every day, potentially helping regulate hunger cues throughout the day• 90% maintain high levels of physical activity, averaging over an hour daily (420 minutes weekly)• The study shows no increased psychological symptoms like depression or disordered eating in people who weigh themselves regularly• Reducing TV time may create more opportunities for physical activity and NEAT (non-exercise activity thermogenesis)• Weight maintenance strategies focus on consistency rather than perfectionCheck us out on threads and our website, or email us at yourcheckuppod@gmail.com. Next week, expect an episode about the flu vaccine as we head into the season.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

In this episode of American Glutton, Ethan Suplee sits down with Dave Knapp, patient advocate and founder of the first patient-centric obesity medicine news platform. Dave shares his deeply personal journey with obesity and type 2 diabetes—from years of yo-yo dieting and keto struggles to discovering GLP-1 medications that changed his life.Together, Ethan and Dave explore misconceptions about obesity, the emotional toll of weight loss, the rise of new medical treatments, and the importance of community in navigating these challenges. This honest, eye-opening conversation is filled with hard truths, hope, and inspiration for anyone on a health journey.SHOW HIGHLIGHTS 00:02 – Welcome and introductions 01:18 – Living with diabetes and obesity 04:40 – Obesity as a chronic disease 08:29 – Misconceptions about type 2 diabetes 10:22 – High school struggles and keto beginnings 13:36 – Diagnosis and the wake-up call 15:51 – Year of keto and frustration 23:24 – Facing surgery and discovering new drugs 26:35 – Building a patient-driven platform 33:46 – Safety concerns and misconceptions 41:46 – Why people resist obesity medications 46:32 – Transfer addiction and mental health 52:06 – Long-term effects and unanswered questions 56:27 – Loose skin and hidden struggles of weight loss 01:00:39 – The misconceptions about rapid results 01:02:55 – Final reflections and gratitude Hosted on Acast. See acast.com/privacy for more information.